Metabolic syndrome management
Autor: | Lowell R Schmeltz, Neil J. Stone |
---|---|
Rok vydání: | 2007 |
Předmět: |
medicine.medical_specialty
Coronary Artery Disease Bioinformatics Coronary artery disease Insulin resistance Weight loss Risk Factors Internal medicine medicine Animals Humans Pharmacology (medical) Pharmacology Metabolic Syndrome business.industry Type 2 Diabetes Mellitus Disease Management General Medicine medicine.disease Obesity Endocrinology medicine.symptom Metabolic syndrome business Weight gain Dyslipidemia |
Zdroj: | Expert opinion on pharmacotherapy. 8(13) |
ISSN: | 1744-7666 |
Popis: | Overweight, obesity and the metabolic syndrome occur in genetically susceptible individuals with environmental influences, and may be further compounded by other disorders of metabolism or pharmacological therapy that increase insulin resistance or promotes weight gain. Treatment of the metabolic syndrome should focus on treatment on [corrected] each individual component, but first, lifestyle modification, including diet and exercise with weight reduction, should be [corrected] the foundation of any successful treatment regimen for the metabolic syndrome. Pharmacological therapy should be individualized and targeted to normalize blood pressure, HDL cholesterol, triglycerides and glucose values. If successful, comprehensive management of the metabolic syndrome promises to delay or prevent the development of coronary heart disease and Type 2 diabetes mellitus. |
Databáze: | OpenAIRE |
Externí odkaz: |